Of the 14 patients that were diagnosed with demyelinating disease (DD), 2 had relapsing-remitting MS, 1 had a clinically isolated syndrome, 3 had tumefactive MS, 3 were classified as untyped or neurodegenerative MS, 4 had ADEM, and 1 had anti-MOG syndrome. The gene discussed is MOG; the disease is relapsing-remitting multiple sclerosis.